Michael Davin - Cynosure Chairman and CEO

Chairman

Mr. Michael R. Davin is Chairman of the Board, President, Chief Executive Officer of Company. Mr. Davin was our chief executive officer and a director since September 2003, and became the chairman of our board of directors in October 2004. From 2003 to 2014, he also served as our president. Mr. Davin has over 25 years of experience in the lightbased technology field. From 1998 to 2003, Mr. Davin served as cofounder and vice president of worldwide sales and strategic development of Cutera, Inc., a provider of laser and other lightbased aesthetic treatment systems. Prior to cofounding Cutera, Mr. Davin spent 11 years at Coherent Medical, a manufacturer of laser, optics and related equipment, in senior management positions in sales, marketing and clinical development since 2016.
Age 57
Tenure 8 years
Phone978 256-4200
Webwww.cynosure.com
Davin’s qualifications to serve on our board of directors include his more than two decades of experience in the lightbased technology industry, including more than 10 years as our chief executive officer.

Cynosure Management Efficiency

The company has return on total asset (ROA) of 0.0194 % which means that it generated a profit of $0.0194 on every $100 spent on assets. This is way below average. Cynosure's management efficiency ratios could be used to measure how well Cynosure manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 18.11 M in liabilities with Debt to Equity (D/E) ratio of 0.04, which may suggest the company is not taking enough advantage from borrowing. Cynosure has a current ratio of 3.25, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Cynosure until it has trouble settling it off, either with new capital or with free cash flow. So, Cynosure's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cynosure sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cynosure to invest in growth at high rates of return. When we think about Cynosure's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 5 records

CHAIRMAN Age

Monte JDStepstone Group
56
Michael LongUsio Inc
72
Michael LongArrow Electronics
65
Robert KamfarBluerock Homes Trust
61
Louis HochUsio Inc
58
Cynosure, Inc. develops, manufactures, and markets aesthetic treatment systems for plastic surgeons, dermatologists, and other medical practitioners. Cynosure (CYNO) is traded on NASDAQ Exchange in USA and employs 857 people.

Management Performance

Cynosure Leadership Team

Elected by the shareholders, the Cynosure's board of directors comprises two types of representatives: Cynosure inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cynosure. The board's role is to monitor Cynosure's management team and ensure that shareholders' interests are well served. Cynosure's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cynosure's outside directors are responsible for providing unbiased perspectives on the board's policies.
Marina Hatsopoulos, Independent Director
Brian Barefoot, Independent Director
William Flannery, Director
Ettore Biagioni, Independent Director
Timothy Baker, President, COO, CFO, Principal Accounting Officer and Treasurer
Stephen Webber, Executive Vice President
Douglas Delaney, Executive VP of Worldwide Sales
Michael Davin, Chairman and CEO
Thomas Robinson, Independent Director
David MacKie, Executive VP of Operations

Cynosure Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cynosure a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Cynosure

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cynosure position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cynosure will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Bristol Myers could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bristol Myers when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bristol Myers - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bristol Myers Squibb to buy it.
The correlation of Bristol Myers is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bristol Myers moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bristol Myers Squibb moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bristol Myers can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Consideration for investing in Cynosure Stock

If you are still planning to invest in Cynosure check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cynosure's history and understand the potential risks before investing.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges